Vol.96 No.11 contentsPRACTICA OTO-RHINO-LARYNGOLOGICA
Vol. 96 No.11 November 2003
The Therapeutic Efficacy of
IPD®
for Patients
with Pollinosis due to Japanese Ceder
Toshihisa Ito, Shigeharu Fujieda, Yuichi Kimura, Hideyuki
Yamamoto,
Akihiro Kojima, Takechiyo Yamada and Hitoshi Saito
(Fukui Medical University)
The effect of IPD® (suplatast tosilate) is known to suppress the activity of cytokine production from type 2 helper T cells and IgE. We clinically evaluated the combined efficacy of IPD® and anti-histamine for patients with pollinosis before or during the pollen season. The clinical outcome and quality of life (QOL) score of pollinosis patients were assessed every 2 weeks. The QOL score of the group receiving IPD® and anti-histamine increased significantly compared with that of the group receiving only anti-histamine IPD®. These results suggest that combined therapy with IPD® increases the level of satisfaction with pollinosis treatment.
Key words : IPD® (suplatast tosilate), pollinosis